文献速递乳房整形与再造

化疗与放疗对即刻乳房再造后乳房感觉的影响

Impact of Chemotherapy and Radiation on Breast Sensation After Immediate Reconstruction.
PubMed 文献 · Ann Plast Surg · 2025-01-01

这项前瞻性研究纳入2019至2024年291例乳房切除即刻再造患者,采用压力指定感觉装置进行术前及术后感觉测试。新辅助化疗和术前放疗与术后3至12个月外乳感觉暂时下降相关,辅助放疗导致广泛持续的感觉缺陷,辅助化疗对假体再造无影响但与DIEP皮瓣再造外乳感觉长期下降相关。

要点

  • 辅助放疗(β=13.06)、新辅助化疗(β=5.99)和高BMI(β=0.71)是乳房感觉减弱的显著危险因素(P=0.05)。
  • 神经化DIEP皮瓣再造(β=-7.82)和术后时间较长(β=-1.56)为保护因素(P<0.001)。
  • 辅助化疗对假体再造感觉无影响,但与DIEP皮瓣再造外乳区域长期感觉下降相关。

核心结论

  • 辅助肿瘤治疗尤其是辅助放疗对乳房感觉有不利影响,此信息有助于术前咨询并帮助乳腺癌患者建立现实预期。

研究设计与样本

  • 前瞻性研究,2019至2024年纳入291例乳房切除即刻假体或神经化DIEP皮瓣再造患者,共154例(274只乳房)假体再造和137例(248只乳房)DIEP皮瓣再造。

主要发现

  • 新辅助化疗和术前放疗与术后3至12个月外乳感觉暂时下降相关,辅助放疗导致广泛持续的感觉缺陷。
  • 辅助化疗对假体再造感觉无影响,但与DIEP皮瓣再造外乳区域长期感觉下降相关。
  • 回归分析显示辅助放疗(β=13.06)、新辅助化疗(β=5.99)和高BMI(β=0.71)为乳房感觉减弱的显著危险因素(P=0.05)。
  • 神经化DIEP皮瓣再造(β=-7.82)和术后时间较长(β=-1.56)为保护因素(P<0.001)。

关键数值与推荐

  • 各治疗组与相应对照组感觉评分采用非配对两样本t检验比较,随后用混合效应向后线性回归模型评估各治疗的相对影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study explores the impact of chemotherapy and radiation therapy (XRT) on breast sensation in patients undergoing mastectomy with immediate reconstruction. METHODS: This prospective study, conducted from 2019 to 2024, focused on patients undergoing mastectomy with immediate implant-based or neurotized deep inferior epigastric perforator (DIEP) flap reconstruction. Neurosensory testing was performed preoperatively and at defined postoperative intervals using a pressure-specified sensory device. Patients were stratified by type of reconstruction and oncologic treatment: neoadjuvant chemotherapy, adjuvant chemotherapy, preoperative XRT, and adjuvant XRT. Sensation scores were compared between each treatment group and its corresponding control group using an unpaired two-sample t test. Subsequently, a mixed-effects backward linear regression model was used to assess the relative impact of each treatment. RESULTS: A total of 291 patients were analyzed, including 154 patients (274 breasts) who underwent implant-based reconstruction and 137 patients (248 breasts) who underwent DIEP flap reconstruction. Neoadjuvant chemotherapy and preoperative XRT were associated with temporary reductions in outer breast sensation at 3 to 12 months postoperatively, whereas adjuvant XRT resulted in widespread and persistent sensory deficits. Adjuvant chemotherapy had no impact on sensation in implant-based reconstructions but was associated with long-term decreased sensation in the outer breast regions of DIEP flap reconstructions. Regression analysis identified adjuvant XRT (β = 13.06), neoadjuvant chemotherapy (β = 5.99), and higher BMI (β = 0.71) as significant risk factors for diminished breast sensation (P = 0.05), whereas neurotized DIEP flap reconstruction (β = -7.82) and a greater time since surgery (β = -1.56) were protective factors (P < 0.001). CONCLUSIONS: These findings highlight the detrimental impacts of adjunctive oncologic therapies, particularly adjuvant XRT, on breast sensation. This information can aid in preoperative counseling and help establish realistic expectations for breast cancer patients considering mastectomy and reconstruction.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Qin N, Gundlach C, Kochheiser M, et al. Impact of Chemotherapy and Radiation on Breast Sensation After Immediate Reconstruction. Ann Plast Surg. 2025. PMID: 40167072. doi:10.1097/SAP.0000000000004289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。